HIV

"HIV" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Descriptor ID	D006678
MeSH Number(s)	B04.820.650.589.650.350
Concept/Terms	HIV HIV Human Immunodeficiency Virus Immunodeficiency Virus, Human Immunodeficiency Viruses, Human Virus, Human Immunodeficiency Viruses, Human Immunodeficiency Human Immunodeficiency Viruses Human T Cell Lymphotropic Virus Type III Human T-Cell Lymphotropic Virus Type III Human T-Cell Leukemia Virus Type III Human T Cell Leukemia Virus Type III LAV-HTLV-III Lymphadenopathy-Associated Virus Lymphadenopathy Associated Virus Lymphadenopathy-Associated Viruses Virus, Lymphadenopathy-Associated Viruses, Lymphadenopathy-Associated Human T Lymphotropic Virus Type III Human T-Lymphotropic Virus Type III AIDS Virus AIDS Viruses Virus, AIDS Viruses, AIDS Acquired Immune Deficiency Syndrome Virus Acquired Immunodeficiency Syndrome Virus HTLV-III

Below are MeSH descriptors whose meaning is more general than "HIV".

Organisms [B]
Viruses [B04]
RNA Viruses [B04.820]
Retroviridae [B04.820.650]
Lentivirus [B04.820.650.589]
Lentiviruses, Primate [B04.820.650.589.650]
HIV [B04.820.650.589.650.350]

Below are MeSH descriptors whose meaning is related to "HIV".

Below are MeSH descriptors whose meaning is more specific than "HIV".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV" by people in this website by year, and whether "HIV" was a major or minor topic of these publications.

Bar chart showing 68 publications over 21 distinct years, with a maximum of 7 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2002	1	2	3
2004	2	0	2
2005	1	2	3
2006	4	2	6
2007	3	1	4
2008	1	0	1
2009	3	0	3
2010	3	1	4
2011	0	2	2
2012	2	1	3
2013	2	3	5
2015	1	1	2
2016	1	1	2
2017	2	0	2
2018	1	3	4
2019	0	4	4
2020	2	5	7
2021	1	3	4
2022	0	4	4
2023	1	1	2

Below are the most recent publications written about "HIV" by people in Profiles.

Muiru AN, Madden E, Scherzer R, Horberg MA, Silverberg MJ, Klein MB, Mayor AM, John Gill M, Napravnik S, Crane HM, Marconi VC, Koethe JR, Abraham AG, Althoff KN, Lucas GM, Moore RD, Shlipak MG, Estrella MM. Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study. Clin Infect Dis. 2023 02 08; 76(3):461-468.

View in: PubMed
Bolzenius J, Sacdalan C, Ndhlovu LC, Sailasuta N, Trautmann L, Tipsuk S, Crowell TA, Suttichom D, Colby DJ, Phanuphak N, Chan P, Premeaux T, Kroon E, Vasan S, Hsu DC, Valcour V, Ananworanich J, Robb ML, Ake JA, Pohl KM, Sriplienchan S, Spudich S, Paul R. Brain volumetrics differ by Fiebig stage in acute HIV infection. AIDS. 2023 05 01; 37(6):861-869.

View in: PubMed
Adeyeba MO, Montazeri Q, Bivens-Davis T, Schrode KM, Harawa NT. Reducing Human Immunodeficiency Virus and Sexually Transmitted Infections Risk in African American Women with At-Risk Male Partners: A Randomized Trial. J Womens Health (Larchmt). 2023 03; 32(3):311-322.

View in: PubMed
Xiao P, Gumber S, Marzinke MA, Hoang T, Myers R, Date AA, Hanes J, Ensign LM, Wang L, Rohan LC, Cone R, Fuchs EJ, Hendrix CW, Villinger F. Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques. JCI Insight. 2022 12 08; 7(23).

View in: PubMed
Lee F, Khanna AS, Hallmark CJ, Lavingia R, McNeese M, Zhao J, McNeese ML, Khuwaja S, Ardestani BM, Collier N, Ozik J, Hotton AL, Harawa NT, Schneider JA, Fujimoto K. Expanding Medicaid to Reduce Human Immunodeficiency Virus Transmission in Houston, Texas: Insights From a Modeling Study. Med Care. 2023 01 01; 61(1):12-19.

View in: PubMed
Olaleye OA, Zash R, Diseko M, Mayondi G, Mabuta J, Lockman S, Melton ML, Mmalane M, Makhema J, Shapiro RL. Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus?on birth outcomes in Botswana. Trop Med Int Health. 2022 11; 27(11):990-998.

View in: PubMed
Adeniji OS, Kuri-Cervantes L, Yu C, Xu Z, Ho M, Chew GM, Shikuma C, Tomescu C, George AF, Roan NR, Ndhlovu LC, Liu Q, Muthumani K, Weiner DB, Betts MR, Xiao H, Abdel-Mohsen M. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells. PLoS Pathog. 2021 11; 17(11):e1010034.

View in: PubMed
Hellmuth J, Muccini C, Colby DJ, Kroon E, de Souza M, Crowell TA, Chan P, Sacdalan C, Intasan J, Benjapornpong K, Tipsuk S, Puttamaswin S, Chomchey N, Valcour V, Sarnecki M, Tomaka F, Krebs SJ, Slike BM, Jagodzinski LL, Dumrongpisutikul N, Sailasuta N, Samboju V, Michael NL, Robb ML, Vasan S, Ananworanich J, Phanuphak P, Phanuphak N, Paul R, Spudich S. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 10 05; 73(7):e1885-e1892.

View in: PubMed
Rebeiro PF, Jenkins CA, Bian A, Lake JE, Bourgi K, Moore RD, Horberg MA, Matthews WC, Silverberg MJ, Thorne J, Mayor AM, Lima VD, Palella FJ, Saag MS, Althoff KN, Gill MJ, Wong C, Klein MB, Crane HM, Marconi VC, Shepherd BE, Sterling TR, Koethe JR. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada. Clin Infect Dis. 2021 10 05; 73(7):e2234-e2242.

View in: PubMed
Silverberg MJ, Leyden W, Hern?ndez-Ram?rez RU, Qin L, Lin H, Justice AC, Hessol NA, Achenbach CJ, D'Souza G, Engels EA, Althoff KN, Mayor AM, Sterling TR, Kitahata MM, Bosch RJ, Saag MS, Rabkin CS, Horberg MA, Gill MJ, Grover S, Mathews WC, Li J, Crane HM, Gange SJ, Lau B, Moore RD, Dubrow R, Neugebauer RS. Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 06 01; 72(11):1900-1909.

View in: PubMed

People

Explore

Similar Concepts

Top Journals